Soft Tissue Sarcoma Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024
Types of Soft tissue Sarcoma and treatment options
Soft Tissue Sarcoma Treatment Market: Soft tissues such as blood vessels, muscles, fats, nerves and deep skin tissues, etc. suffer from a rare and diverse group of cancers is known as soft tissue sarcoma. There are 50 different types of soft tissue sarcoma that can cause different types of sarcoma such as liposarcomas which are developed from fat cells and leiomyosarcomas which are developed from smooth muscle tissues. The soft tissue sarcoma can be treated by combining chemotherapy, radiotherapy, and surgery to remove the tumor. If surgery is not required, chemotherapy alone can work well.
A sample of this report is available upon request @
In approaching years, the soft tissue sarcoma market is expected to rise due to many reasons which include a rise in the number of soft tissue sarcoma cases, increase in the different types of cancers, patent expiration of drugs, increase in healthcare expenditure and increase in the R & D activities on the drugs. With that being said, the high cost of chemotherapy, radiotherapy, regulatory guidelines and adverse side effects linked with the treatment can hamper the growth of soft tissue sarcoma market in upcoming years.
The soft tissue sarcoma treatment market is divided into three categories. They are as follows-
- Based on the treatment type
- Targeted therapy
- Chemotherapy
- Anti-angiogenesis drugs
- Radiation therapy
- Internal radiation therapy
- External radiation therapy
- Based on disease type
- Local sarcoma
- Regional sarcoma
- Metastatic sarcoma
- Based on end-user
- Hospitals pharmacies, retail pharmacies and long term care centers.
To view TOC of this report is available upon request @
From a market point of view for soft tissue sarcoma treatment, the regions are divided into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Due to increase in the prevalence of the soft tissue sarcoma, North America leads its way. According to American Cancer Society, approximately 12,390 people were suffering from soft tissue sarcomas in 2016. Following North America, Europe has their fair share in contributing to the soft tissue sarcoma treatment market. With the increase in awareness, lifestyle changes, R & D for new drugs can cause a significant increase in the awareness of the soft tissue sarcoma treatment market.
Need more information about this report @
The market for soft tissue sarcoma treatment is slowly growing with fewer products which are also approved for treatment of various types of soft tissue sarcoma. Once such international company which has made exceptional progress in this soft tissue sarcoma treatment market is Threshold Pharmaceuticals Inc. has developed a product named Evofosfamide, which is a first line drug for soft tissue sarcoma treatment. Threshold Pharmaceuticals has co-developed this product with Merck KGaA. Following their progress, GSK’s Votrient (Pazopanib) is approved for second-line treatment for soft tissue sarcoma. Apart from all these medicines, Aldoxorubicin and Doxorubicin are widely used in the treatment of soft tissue sarcoma.
Some important names among the soft tissue sarcoma treatment market are Eli Lilly and company (U.S), GSK (U.K), Pfizer, Inc. (U.S), Teva Pharmaceutical Industries Ltd (Israel), Bristol-Myers Squibb (U.S), etc. In 2016, U.S. FDA had approved brand name drug Lartruvo (Olaratumab) with Doxorubicin to treat few types of soft tissue sarcomas.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553